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Abstract Electrolyte alterations and extra-renal disorders are
quite frequent in patients undergoing haemodialysis or perito-
neal dialysis. The native kidneys may be the site of important
pathologies in patients undergoing dialysis, especially in the
form of acquired renal cystic disease with frequent malignant
transformation. Renal neoplasms represents an important
complication of haemodialysis-associated acquired cystic kid-
ney disease and imaging surveillance is suggested. Extra-renal
complications include renal osteodistrophy, brown tumours,
and thoracic and cardiovascular complications. Other impor-
tant fields in which imaging techniques may provide impor-
tant informations are arteriovenous fistula and graft
complications.
Teaching points
• Renal neoplasms represent a dreaded complication of
haemodialysis.
• In renal osteodystrophy bone resorption typically manifests
along the middle phalanges.
• Brown tumours are wel l -def ined ly t ic les ions
radiographically, possibly causing bone expansion.
• Vascular calcifications are very common in patients under-
going haemodialysis.
• Principal complications of the AV fistula consist of
thrombosis, aneurysms and pseudoaneurysms.
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Introduction
End-stage renal disease occurs when chronic renal failure pro-
gresses to the point that the kidneys are permanently function-
ing at less than 10 % of their capacity, namely the glomerular
filtration rate (GFR) is permanently lower than 15 ml/min/
1.73 m2. End-stage renal disease used to be a lethal condition
until the advent of long-term haemodialysis and renal trans-
plantation. In the USA, diabetic nephropathy, hypertension
and glomerulonephritis cause approximately 75 % of end-
stage renal disease in patients undergoing haemodialysis.
The dialysis is the exchange of solutes and waste products
via either an extracorporeal membrane (haemodialysis) or a
peritoneal membrane (continuous ambulatory or cycling peri-
toneal dialysis). As far as haemodialysis is concerned, the sol-
ute removal primarily depends on passive diffusion across a
semipermeable membrane. Blood and dialysate flow rates are
adjusted to replenish the supply of incoming solute available
for diffusion [1]. The efficiency of ultrafiltration depends on the
water permeability of the device and the surface area [1].
Haemodialysis has a higher clearance rate for low-molecular-
weight substances such as urea [1]. Peritoneal dialysis should
be performed in infants and patients with relative contraindica-
tions to haemodialysis such as severe vascular disease, active
bleeding, haemorrhagic diathesis or cardiovascular instability.
The clinical constellation of signs and symptoms of end-
stage renal disease is known as uraemic syndrome. Various
problems related to the vascular access in patients on
haemodialysis [2] are also common since the peritoneal dial-
ysis catheter leads to the risk of peritonitis and local infections.
Patients with end-stage renal failure are susceptible to all the
complications of any underlying condition such as diabetes
and hypertension as well as other metabolic and physiologic
derangements. In addition, chronic immunosuppression
makes patients with end-stage renal disease prone to infec-
tions, tuberculosis included [3].
F. Degrassi (*) : E. Quaia : P. Martingano :M. Cavallaro :
M. A. Cova
Department of Radiology, Cattinara Hospital, University of Trieste,
Strada di Fiume 447, 34149 Trieste, Italy
e-mail: ferruccio.degrassi@alice.it
Insights Imaging (2015) 6:309–321
DOI 10.1007/s13244-015-0383-3
Imaging plays an essential role in the assessment of the
possible renal and extra-renal complications in patients under-
going long-term haemodialysis.
Chronic renal failure
Chronic renal failure can result from numerous renal paren-
chymal diseases, the most common being glomerulonephritis,
diabetes, hypertension and the polycystic kidney disease. Di-
abetes and hypertension are now recognised as the leading
causes of chronic renal failure in the USA [4]. Often, patients
only seek medical attention when the renal disease has
progressed to the uraemic stage since adult patients are usually
unaware of their advancing renal failure until the GFR has
decreased to less than 15 ml per minute, namely end-stage
renal disease [4].
Ultrasound (US) with Doppler US examination of
intrarenal vessels is the imaging modality of choice to be
employed in patients with renal failure and is commonly per-
formed early in the clinical course [5]. Chronic renal failure
manifests with a reduction of renal dimensions that develops
over months or years. US reveals a reduced renal length and
reduced renal cortical thickness with an increased renal corti-
cal echogenicity often associated with poor visibility of the
renal pyramids and the renal sinus, marginal irregularities,
parenchymal cysts and also papillary calcifications (Fig. 1a–
b). Colour Doppler US reveals a reduced renal vascularity and
increased RI values measured at the level of the segmental and
interlobular arteries [6, 7] according to the stage of chronic
renal failure. The capability of renal RI to aid in the prediction
of renal dysfunction progression has been demonstrated. US
follow-up of native scarred kidneys is indicated in patients
with chronic renal failure treated with dialysis or renal trans-
plantation because they develop the acquired cystic kidney
disease (ACKD) with a significantly increased risk of solid
and cystic renal malignancies. CTconfirms the US findings by
revealing reduced renal length and cortical thickness (Fig. 2).
Renal abnormalities in long-term haemodialysis
Acquired cystic kidney disease
ACKD was first described by Dunnil et al. (1977) and is
characterised by the development of numerous fluid-filled
cysts in patients with end-stage renal disease who have under-
gone prolonged dialysis but without a history of hereditary
cystic disease (Fig. 3a, b). After 1–3 years of haemodialysis,
10–20 % of patients have ACKD, 40–60 % after 3–5 years of
haemodyalisis and more than 90 % after 5–10 years of
haemodialysis. The cysts measure 0.5 to 2 cm in diameter,
contain clear fluid, are lined by either a hyperplastic or a
flattened tubular epithelium, and often contain calcium oxa-
late crystals. They probably form as a result of obstruction of
tubules by interstitial fibrosis or oxalate crystals. Frequently,
some cysts may develop a haemorrhagic pattern causing
Fig. 1 a–b: a Grey-scale US and (b) unenhanced CT, coronal
reformations. Papillary calcifications in a patient undergoing long-term
dialysis, appearing as hyperchoic spots on renal pyramids. Papillary
calcifications may also be observed in analgesic nephropathy, in
sarcoidosis, primary hyperparathyroidism, diabetes mellitus and
medullary sponge kidney
Fig. 2 Chronic renal failure in a 76-year-old female. CT image of
kidneys reveals a short length and diffuse reduction of renal cortical
thickness
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haematuria (Fig. 4a, b). The likelihood of the development of
ACKD increases with the duration of haemodialysis, and it is
higher in male and older patients. Other factors such as the
underlying renal insufficiency and serum creatinine level have
no significant influence on the development of ACKD. The
development of renal cell carcinoma in the wall of the cysts is
the most serious complication of ACKD. The prevalence of
renal cell carcinoma in patients with dialysis-associated
ACKD undergoing long-term haemodialysis is increased, be-
ing in the range of 3–6 %. The prevalence is similar in patients
with ACKD undergoing renal transplantation.
Renal neoplasms
An increased incidence of renal tumours has been reported in
patients with end-stage renal disease [8]. Renal cell carcinoma
(RCC) presents with a frequency three to six times higher in
patients receiving haemodialysis than in the general popula-
tion [8]. Observations provide histological evidence that renal
cell neoplasms are prone to develop in relatively young pa-
tients with renal failure when their uraemia is treated by long-
term dialysis. The incidence of renal carcinoma increases with
the duration of dialysis [8].
Other studies indicate that the stimulus for neoplastic
growth comes with a cystic transformation of the kidneys. A
very strong association with ACKD and an increased inci-
dence of papillary renal tumours have been observed in many
studies [9].More than 80% of all patients with end-stage renal
disease developing a renal tumour actually have underlying
ACKD [8]. Since these tumours are multiple and very often
small in size, the ratio of histological RCC subtypes is shifted
toward papillary renal carcinoma and papillary renal cell ade-
noma [8].
Fig. 3 a, b: Unenhanced (a) and contrast-enhanced CT (b). Acquired
cystic kidney disease in a patient undergoing long-term haemodialysis
Fig. 4 a, b: Haemorrhagic renal cyst (arrow) in the right kidney in a
patient undergoing long-term haemodialysis. The cyst appears
hypointense on T2-weighted MR sequences (a) and hyperintense on
T1-weighted MR sequences (b)
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Renal tumours developing in patients undergoing
haemodialysis present at an earlier age compared to the gen-
eral population, with a higher incidence in males, [8, 10–12],
and they frequently are bilateral (9 %) and multi-centric
(50 %) [5]. The papillary hyperplasia in the cyst is thought
to be a precursor of the papillary carcinoma. Papillary-cell
renal cell carcinoma accounts for about half the cases identi-
fied in patients undergoing haemodialysis, while it does not
exceed 10 % in the general population (Fig. 5a–c) [13–16].
CT seems to provide better diagnostic accuracy than US or
MR imaging in the detection of renal tumours in patients
undergoing haemodialysis (Fig. 6a–c) [17, 18].
The leading sign of the tumour is the space occupied by the
lesion localised in the atrophic renal parenchyma; the size of
the distinguishable tumour is about 5 mm in diameter when
causing the bulging of the renal surface [9]. Smaller lesions
under the kidney surface may remain undetected, especially
when ultrasound or plain CT is used [19]. Renal parenchymal
atrophy in the end stage of glomerulonephritis or interstitial
nephritis is the main limitation of ultrasound in imaging the
kidneys in dialysis patients [9], while the enhancement of
small nodular foci could help identify smaller tumours inside
the renal parenchyma if multi-detector row computed tomog-
raphy with isotropic resolution is used [9].
It is generally agreed that there is a need for regular sur-
veillance of patients with ACKD for the early detection of
renal cell carcinoma [17, 18].
Although regular follow-up trans-abdominal ultrasound
or conventional helical CT is able to detect larger masses,
Ferda et al. have shown that the capabilities of multi-
detector row computed tomography offer more accurate
imaging of multiple renal tumours in ESRD patients [9].
However, some authors maintain that the performance of
periodic ultrasound controls allows achieving the early di-
agnosis and treatment of tumours of the kidney in patients
in dialysis [20].
There is no clear consensus about screening in the long-
term dialysis population. The current literature indicates that
most patients will develop acquired renal cysts after 3–7 years
on dialysis, the latter associated with a 1.6–7.0 % incidence of
Fig. 5 a–c: Unenhanced (a) and
contrast-enhanced CT, transverse
plane (b) and sagittal reformation
(c). Rounded lesion (white arrow)
of the right kidney in a patient
after renal allograft
transplantation (black arrow).
The lesion shows indeterminate
enhancement (an increase of
10 HU after contrast injection).
The dissected specimen proved to
be a papillary renal cell
carcinoma. There was no sign of
acquired cystic renal disease
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RCC. This has led some authors to recommend routine
screening for RCC in patients who have been on dialysis for
longer than 3 years, including subsequent transplant recipients
[21]. Some authors have found that screening with computed
tomography or ultrasound increases life expectancy by about
1.6 years among 20-year-old patients with a life expectancy of
25 years [22].
Extra-renal complications in patients undergoing
long-term haemodialysis
Musculoskeletal system
Patients with chronic renal disease and on haemodialysis may
develop many different musculoskeletal abnormalities, in-
cluding secondary hyperparathyroidism, osteomalacia,
osteosclerosis, osteoporosis, amyloidosis and a variety of
crystal deposition diseases [23].
Other abnormalities related to the biochemical disturbance
of chronic renal failure include soft tissue/vascular calcifica-
tions and crystalline arthropathies.
Musculoskeletal sequelae predominantly related to dialysis
include an aluminium toxicity manifesting as osteomalacia
from ingestion of aluminium salts in phosphate-binding
antiacids used to control hyperphosphataemia, amyloidosis
and destructive spondyloarthropathy.
Dialysis-related amyloidosis is a frequent and major com-
plication in long-term dialysis patients, and it presents with
carpal tunnel syndrome, cystic bone lesions, destructive
spondylarthropathy, arthritis, periarthritis and systemic organ
involvement [24].
Destructive spondyloarthropathy is characterised by rapid-
ly progressive radiographic abnormalities, including the loss
of intervertebral disc space, erosion of the subchondral bone in
the adjacent vertebral bodies and new bone formation (Fig. 7).
In some patients, destructive changes may be severe, simulat-
ing infective spondylitis: the persistence of low signal inten-
sity on T2-weighted images generally permits excluding in-
fections [23].
Avascular necrosis, osteomyelitis (Fig. 8a, b), septic arthri-
tis, tendinosis/tendon rupture and bursitis/synovitis are caused
by a combination of chronic renal failure, steroid/
immunosuppressants and dialysis [25].
Fig. 6 a–c: ACKD in a patient who has been undergoing haemodialysis
for 10 years. a Unenhanced and contrast-enhanced CT, transverse plane
(b) and coronal reformation (c). Both kidneys present multiple cysts; one
of these at the inferior pole of the left kidney presents uniform thickening
of the wall (Bosniak IIF) (arrowhead). Moreover a solid enhancing
lesion, about 3 cm in size, is evident on the left kidney (arrow)
corresponding to a clear-cell renal cell carcinoma
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Renal osteodystrophy
Abnormalities involving the musculoskeletal system are nu-
merous and frequent in patients with chronic renal insufficien-
cy. Chronic renal insufficiency, haemodialysis, peritoneal dial-
ysis, renal transplantation and administration of different med-
ications provoke complex biochemical disturbances of the
calcium-phosphate metabolism with a wide spectrum of bone
and soft tissue abnormalities named renal osteodystrophy [26].
Renal osteodystrophy is a global term applied to all patholog-
ical features of bone in patients with chronic renal failure and it
includes osteomalacia or rickets according to the age of the
patient, secondary hyperparathyroidism with bone resorption,
periosteal reaction, brown tumours, osteosclerosis, osteoporo-
sis, soft tissue and vascular calcifications.
Mult iple factors play a role in creat ing renal
osteodystrophy including a deficiency in the active form of
vitamin D due to impaired renal metabolism and an increase in
the parathormone secretion due to hyperphosphataemia caus-
ing hypocalcaemia by precipitating calcium [5].
Radiography still represents the most important and widely
performed technique [27] to identify the alterations of renal
osteodystrophy. Radionuclide imaging, computed tomogra-
phy and magnetic resonance imaging are less frequently indi-
cated and are mainly used for more sensitive and precise iden-
tifications (aseptic bone necrosis, infection, Looser’s zones),
morphological presentations (spinal infection with neural
compromise) and the differential diagnosis of complications
(destructive spondyloarthropathy versus spinal infection).
The osteoclastic bone resorption affects the surfaces of the
bone and may be subperiosteal, intracortical, endosteal, tra-
becular, subchondral, subligamentous and subtendinous. Ear-
ly radiographic changes of subperiosteal bone resorption may
be demonstrated at the phalangeal tufts and the radial aspects
of the middle phalanges of the second and the third hand
fingers (Fig. 9a, b) [26]. Early subperiosteal resorption pro-
duces the loss of definition of the cortical bone with a charac-
teristic lace-like appearance, which later on progresses to
Fig. 7 Plain x-ray film of the spine. Diffuse osteosclerosis of the spine in
a patient undergoing chronic haemodialysis. Diffuse sub-endplate
densities at multiple contiguous levels (arrows), a pattern known as
“rugger-jersey spine”
Fig. 8 a, b: Unhenanced CTaxial (a), sagittal plane. Osteomyelitis of the
tarsus in a 72-year-old male with chronic renal failure under dialysis.
Extensive bone alterations involving all the tarsal bones with important
areas of ostelysis associated with areas of osteosclerosis. The infection
extensively involves the calcaneus with intraosseous fluid and gas
components. A fistula with subcutaneous soft tissue is visible on the
lateral side of the calcaneus (arrow)
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complete cortical disappearance. The advanced bone resorp-
tion of the terminal phalanges may result in acro-osteolysis
with separation of the tuft and the base of the phalanx.
Subperiosteal resorption is frequently combined with
intracortical tunnelling and endosteal resorption, which causes
scalloped defects of the inner cortical contour. In advanced
disease, the widespread trabecular resorption within the med-
ullary bone may be seen with a loss of definition and the
disappearance of trabeculae. The most typical manifestation
of trabecular bone resorption appears at the cranial vault and is
named the ‘salt and pepper’ skull [26].
Subchondral bone resorption may affect different articula-
tions, most commonly the sacroiliac, sternoclavicular and
acromioclavicular joints, intervertebral discs and the symphy-
sis pubis. Radiographic changes at the sacroiliac joints are
similar to those seen in ankylosing spondylitis and include
the widening of the joint space and subchondral bone erosions
surrounded by osteosclerosis [26].
Subligamentous and subtendinous bone resorption occurs
at numerous sites, especially at the ischial tuberosities, femo-
ral trochanters and the insertions of the coracoclavicular
ligaments.
Periosteal new bone production may be seen in patients
with advanced hyperparathyroidism affecting the metatarsals,
femur, pelvis, humerus, radius, ulna, metacarpals and
phalanges.
Osteosclerosis is frequently found in patients with renal
osteodystrophy and secondary hyperparathyroidism
(Fig. 10a, b). Bone sclerosis in renal osteodystrophy may af-
fect different skeletal elements but it usually predominates in
the axial skeleton. One of the typical findings includes broad
osteosclerosis localised below the endplates of the vertebral
bodies with normal density of the middle parts (‘rugger jersey’
appearance) [26].
Radiographic signs of osteomalacia are a bone density de-
crease with a loss of definition of the cortical bone and coars-
ening of the trabecular pattern. Looser’s zones (i.e. Milkman’s
fractures, pseudofractures) are rare but pathognomic features,
which are most common in the medial part of the femoral
neck, pubic rami, ilii, scapulae, ribs and acromion. Looser’s
zones represent unmineralised osteoid and are seen as lucent
lines perpendicular to the cortex, frequently symmetric in
location.
Rickets-like changes may occur in the immature skeleton
and reflect an abnormal endochondral ossification. Radio-
graphic features include osteopenia with softening and bend-
ing of bones, widening of the growth plate as well as the
cupping, expansion, demineralisation and disorganisation of
the metaphysis [26].
The osteoporotic bone is characterised by the thinning of
cortices and trabeculae. These features are most evident in
skeletal elements rich in cancellous bone (spine, proximal
femur and forearm). In advanced osteoporosis the loss of tra-
beculae with pathological fractures may occur. In the vertebral
column the disappearance of transverse trabeculae with pres-
ervation of the vertical compression trabeculae results in char-
acteristic vertical striations. The final results are pathological
fractures with wedge-shaped, biconcave (fish vertebrae) or
Fig. 9 a, b: aRadiographic image of the left hand in a patient undergoing
chronic haemodialysis. bMagnification. Secondary hyperparathyroidism
with bone resorption along the radial aspects of the middle phalanges of
the fingers (arrows)
Fig. 10 a, b: Unenhanced CT. Sacral region, axial plane (a) and coronal
reformation (b). Renal osteodystrophy of the left iliac wing with diffuse
bone sclerosis and some areas of resorption (arrows) due to secondary
hyperparathyroidism in a patient undergoing chronic haemodialysis
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flattened vertebral bodies and vertebral column deformities.
Vertebral fractures can be evaluated subjectively or using
quantitative methods. In general, the sensitivity of radiogra-
phy is poor; 30 % to 50 % of bone tissue has to be lost before
osteoporosis can be detected on routine radiographs [26].
Brown tumours
Brown tumours are a form of cystic fibrous osteitis, the end
stage of bone remodelling in primary or secondary hyperpara-
thyroidism [28]. In patients with chronic renal failure brown
tumours represent an extreme and serious complication of
renal osteodystrophy [28–31]. Brown tumours are caused by
the localised replacement of bone by vascularised fibrous tis-
sue (osteitis fibrosa cystica) resulting from parathyroid
hormone-stimulated osteoclastic activity [5]. Patients with re-
nal osteodystrophy who have brown tumours actually have
autonomously functioning parathyroid glands or tertiary hy-
perparathyroidism [5]. The fibrous tissue contains giant cells,
and the lesions may become cystic, following necrosis and
liquefaction [5]. These lesions represent a reparative cellular
process rather than a neoplastic process and are located in
areas of intense bone resorption (Fig. 11a, b) [5, 32].
Brown tumours occur as single or multiple radiolucent le-
sions and can be found both within bone and in the adjacent
soft tissues. When left untreated, they can undergo central
necrosis and cyst formation [5]. Radiographically, brown tu-
mours are well-defined lytic lesions, often eccentric or corti-
cal, that may cause endosteal scalloping and bone expansion.
Soft tissue and vascular metastatic calcification
Biochemical disturbance of chronic renal failure includes vas-
cular and soft tissue metastatic calcifications and crystalline
arthropathies. Vascular calcifications manifest as both medial
and intimal calcifications of the arteries and are a hallmark of
the accelerated atherosclerosis observed in uraemia [33].
Calcific uraemic arteriolopathy is a rare but life-threatening
complication estimated to occur in 1 % of patients with chronic
renal disease and in 4.1 % of patients undergoing maintenance
haemodialysis [34]. Articular calcinosis is characterised by the
deposition of a large amount of calcium around the periarticular
regions, and it is commonly noticed over the shoulder, elbow
and hip joints [35]. Even visceral (myocardial and pericardial)
calcifications may occur in patients undergoing haemodialysis.
Vascular calcifications are very common in end-stage renal
disease, especially in patients undergoing haemodialysis
(Fig. 12a, b) [36, 37]. The mechanisms of vascular calcifica-
tion are hyperphosphataemia and elevated calcium (Ca) and
phosphate (P) products [38, 39].
Vascular calcification induces the stiffening of the vessel
wall and reduces the vascular compliance [40]. Iwasa et al.
showed a much higher rate of intracranial artery calcification
in haemodialysis patients than in the general population, and
this finding has been reported to be an independent risk factor
for ischaemic stroke. The most frequently involved sites of
calcification in haemodialysis patients were the internal carot-
id artery and the vertebral arteries [41].
Cardiovascular complications
Cardiovascular complications are common in patients with
chronic renal failure and are related to atherosclerosis and hy-
perlipidaemia, hypertension due to sodium retention and alter-
ations in the renin-angiotensin axis, myocardial dysfunction and
pericarditis. More than 50 % of end-stage renal disease patients
treated with chronic haemodialysis die from cardiovascular dis-
eases, including congestive heart failure due to the increase of
the left ventricular afterload: volume overload between dialyses,
Fig. 11 a, b: Unenhanced CT, coronal (a) and sagittal (b) reformations.
Brown tumour in a patient undergoing chronic haemodialysis with
tertiary hyperparathyroidism. The brown tumour appears as a lytic
lesion of the ilium (arrow)
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hypertension, increased arterial stiffness, anaemia, vascular ac-
cess flow (arteriovenous fistula) and sympathetic activation. Pa-
tients undergoing dialysis present a higher risk of atherosclero-
sis, also for underlying diabetes mellitus and/or hypertension as
causes of end-stage renal disease [4]. Atherosclerosis involves
the main and all the peripheral arteries including the intrarenal
arteries. Calcifications of themyocardium, coronary arteries and
cardiac valves are frequently observed in patients with end-stage
renal disease [40, 42].
Cardiovascular calcification lesions can lead to the devel-
opment of a number of clinically significant complications,
including myocardial ischaemia, myocardial infarction, im-
paired myocardial function, congestive heart failure, cardiac
valve insufficiency and cardiac arrhythmias [43, 44]. It has
been demonstrated that B2-microglobulin amyloid deposits
are extensively localised in the hearts of long-term
haemodyalisis patients [45], in particular at the level of the
endocardium, myocardium and wall of the small vessels [24].
Thoracic complications
Patients with chronic renal failure may present several abnor-
mal findings visible on chest radiography due to changes in the
phosphorus and calcium metabolism, changes in haemostasis,
arterial hypertension, fluid retention or due to dialysis.
The thoracic complications of haemodialysis may be clas-
sified into two main topics: cardiovascular and pulmonary
[46].
Cardiovascular findings include aortic calcification,
cardiomegaly, calcifications of the coronary arteries, pericar-
dial effusion, pulmonary thromboembolism and intra-atrial
thrombus [46].
The most frequent pulmonary abnormalities include inter-
stitial and alveolar oedema due to congestive heart failure,
pleural effusion, lung atelectasis, metastatic pulmonary calci-
fications and calcifications of the bronchial walls, pleura and
chest wall vessels. Lung parenchymal abnormalities visible on
CT include areas of ground-glass opacity, interlobular septal
thickening, parenchymal fibrosis scars, emphysema bullae,
peribronchovascular interstitial thickening, increased vascular
calibre, bronchiectasis, and thickening of the pleura and fis-
sures [46].
The frequency of pulmonary infections in uraemic patients
is higher compared to the general population, with evidence of
parenchymal consolidation and/or pleural effusion [46].
Staphylococcus aureus continues to be the most common
(20.8 %) cause of bacterial infection among patients on long-
term haemodialysis [46]. Patients on haemodialysis are at in-
creased risk of developing active tuberculosis after primary
infection, activation of quiescent disease or reactivation of
pre-existing tuberculosis infection [46].
Neurologic complications
Patients with end-stage renal disease frequently have central
nervous system abnormalities, some of them related to end-
Fig. 12 a, b: Radiographic
images of several skeletal
segments of different patients (all
undergoing long-term
haemodialysis) show diffuse
calcifications of the peripheral
arteries (arrows). Vascular
calcifications appear as both
medial and intimal calcifications
of arteries
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stage renal disease itself and others related to problems sec-
ondary to haemodialysis [47].
The most common neurologic complications in this patient
group include focal white matter lesions, cerebral atrophy,
dialysis encephalopathy, hypertensive encephalopathy, cere-
bral infarction, intracerebral haemorrhage, posterior reversible
encephalopathy syndrome, osmotic demyelination syndrome,
cerebral infection, sinus vein thrombosis and dialysis disequi-
librium syndrome. Peripheral neuropathy is also common in
patients with chronic renal failure [5].
Acute cerebrovascular disease is one of the most frequent
causes of morbidity and mortality in patients on long-term
haemodialysis treatment. Cerebral ischaemia and infarction
are important risk factors for stroke and are caused by the
occlusion of the small, deeply penetrating cerebral arteries.
Haemodialysis patients are at greater risk of cerebral haemor-
rhage because of anticoagulant therapies (e.g., heparin and
low-molecular-weight heparins), defects of platelet adhesion,
anaemia and inadequate control of hypertension. Cerebral
haemorrhage may be intraparenchymal, subdural, epidural or
subarachnoid. Patients with end-stage renal disease also have
predisposing factors that lead to sinus vein thrombosis.
Haematologic abnormalities
Haematologic abnormalities are among the most consistent
manifestations of uraemia [4]. These abnormalities include
anaemia, bleeding and granulocyte and platelet dysfunction.
The primary causes of anaemia in chronic renal failure are de-
ficiency of erythropoietin, which is a glycoprotein normally
produced by the kidney, and iron deficiency due to a reduced
iron intake and frequent blood sampling. Erythropoietin therapy
has improved the general status of patients with chronic renal
failure. In patients with uraemic syndrome the fat bone marrow
is progressively replaced by haematopoietic marrow content
with a hypointense appearance on T1-weighted MR images in
various anatomical regions (especially the spine and upper and
lower limb bones). A haemorrhagic diathesis is common in
patients with chronic renal failure. Spontaneous non-traumatic
bleeding may affect the perinephric and subcapsular spaces,
renal parenchyma or collecting system. Gastrointenstinal bleed-
ing is also common in uraemic patients [5].
Encapsulating peritoneal sclerosis
Although medical considerations may dictate the choice of
continuous ambulatory peritoneal dialysis (CAPD) or
haemodialysis for some patients, most cases of renal failure
are treatable with either method.
Therefore, it is important to recognise some potentially
fatal complications of CAPD that must be detected at an early
stage in order to allow a prompt interruption of CAPD and
direct the patient toward the haemodialysis treatment only.
Encapsulating peritoneal sclerosis is an uncommon serious
complication of CAPD [48] associated with significant mor-
bidity and mortality.
In a large study by Rigby and Hawley [49], the overall
prevalence of encapsulating peritoneal sclerosis is 0.7 %;
however, the prevalence increases to 19.4 % in patients who
have been on CAPD [49] for more than 8 years.
Encapsulating peritoneal sclerosis is a condition
characterised by fibrotic thickening of the peritoneum, which
can progress to the encasement or encapsulation of the small-
bowel loops with a resultant bowel obstruction. The peritoneal
thickening can be smooth or irregular and nodular, and mild
peritoneal thickening typically progresses to diffuse, severe
peritoneal thickening and eventually peritoneal calcification.
Peritoneal thickening progresses to peritoneal encapsula-
tion of the involved small-bowel loops, a process that has been
described as the Bcocooning^ of the small bowel, by a sheath
of fibrous, sclerosed peritoneum.
The small-bowel loops are often centrally collected by en-
capsulating the fibrotic peritoneum. The fibrotic process may
appear as a mass of small bowel loops tethered together. Ulti-
mately, small-bowel necrosis with perforation may occur.
In encapsulating peritoneal sclerosis, the fibrotic, thickened
peritoneal membranes can result in loculated ascites. Since the
small bowel becomes involved, tethered and mass-like, the
tethered small bowel may also produce loculated fluid
collections.
Numerous other complications related to peritoneal dialy-
sis have been described, including catheter dysfunction,
haematoma, dialysate leak and hydrothorax [50].
Dialysis access complications
Repeated access to the circulation is essential to perform an
adequate maintenance haemodialysis. End-stage renal failure
patients requiring long-term haemodialysis need a durable
vascular access, and the maintenance of an acceptable vascu-
lar access is an important issue for patients with renal failure.
Haemodialysis is usually performed with an internal arterio-
venous fistula (AVF) or polytetrafluoroethylene (PTFE, Tef-
lon) graft, also known as a prosthetic bridge graft (PBG).
Surgically constructed arteriovenous (AV) fistulas (radio- or
brachiocephalic), synthetic AV grafts or a venous catheter po-
sitioned in a central vein are common means of establishing a
vascular access for long-term haemodialysis.
Vascular stenosis is the major cause of access failure. The
treatment of stenosis with percutaneous interventions, angio-
plasty, endoluminal vascular stents or thombolysis as an alter-
native to surgery has been shown to increase the chance of
survival for patients with AVF and PBG dialysis [51]. Several
surveillance techniques can be used for the prompt detection
of access stenosis development. Colour Doppler US [52] and
digital subtraction angiography [53] are most commonly used
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for the detection of access stenosis, while contrast-enhanced
multi-detector CT [54] and MR angiography of shunts [55]
have recently been introduced. Angiographic evaluation via
puncture of the brachial artery is indicated when an interven-
tional procedure is planned.
Arteriovenous fistulas
The AV fistula is considered the best long-term vascular ac-
cess for haemodialysis because it provides adequate blood
flow, is long-lasting and has a lower complication rate than
other types of access. A nephrologist or surgeon creates an AV
fistula. As a result, the vein grows larger and stronger, making
repeated needle insertions for haemodialysis treatments easier.
AV fistulas also present some disvantages, including the in-
complete maturation of the vein, and a 1–4-month period may
be required before the AV fistula can be used. Fistula dysfunc-
tion is the most common reason for a second intervention and
recurrent hospitalisation. The rate of AVF complications in-
creases with age and the erythropoietin dose as well as among
patients with a history of a previous failed shunt [56]. The
clinical symptoms include poor flow with loss of thrill in the
graft, enlarging pseudoaneurysm or ipsilateral limb swelling.
The main complications of AV fistula include thrombosis
with occlusion or stenosis of the venous outflow (Fig. 13a, c)
as well as aneurysm or pseudoaneurysm of the venous tract
(Fig. 14a, c) close or distal to the anastomosis with the radial
artery [57]. In particular, the venous outflow obstruction is the
most common cause of AVF thrombosis and poor dialysis.
Most typically, pseudoaneurysms are found in areas of repeat-
ed puncture or surgical anastomosis.
Complications of the arterial tract of AVFs are rare. Prox-
imal arterial disease, the occlusion or arterial anastomotic ste-
nosis are readily shown by digital subtraction angiography.
The arterial stenosis appears as a narrowed area adjacent to
or between areas of graft ectasia. The laceration of the radial
artery may determine a haematoma with compression of the
nervous structures in the carpal tunnel.
Arteriovenous grafts
The AV fistula with its long patency rate and low complication
profile is usually the first choice for vascular access creation.
However, when superficial veins are not suitable for the AV
fistula creation, or they have all been exhausted as a result of
repeated AV fistula procedures, arteriovenous grafts using ex-
panded polytetrafluoroethylene (PTFE) are an alternative
[58]. The PTFE graft—prosthetic bridge graft (PBG)—con-
sists of a synthetic catheter inserted and sutured into an artery,
usually the radial artery, and a vein, usually the cephalic or the
basilic vein.
Unlike the arteriovenous fistula used for chronic
haemodialysis, the AV graft can be used immediately. Just as
in natural AVF, the non-dominant arm should be used first
[58]. Compared to properly formed fistulas, grafts tend to
have more problems with clotting and infections and require
Fig. 13 a–c: An 80-year-old male patient with chronic renal failure
undergoing haemodialysis. Stenosis (about 5 cm in length) of outflow
of AVF of the arm (arrow) (a), treated by angioplasty (b) with recovery
of the normal patency (c)
Fig. 14 a–c: AVF of the forearm at the level of the metaphysis of the
radius in a 70-year-old patient with chronic renal failure under dialysis.
Outflow perianastomotic pseudoaneurysms (arrows). Vein aneurysms or
pseudoaneurysms are located in the puncture site
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earlier replacement. However, a well-cared-for graft can last
several years.
The overall complication rate for AV grafts is twice
as that of AV fistulas. The most common complication
associated with the AV graft is venous outflow obstruc-
tion with graft thrombosis, which accounts for 85 to
90 % of problems with haemodialysis. PBGs have a
shorter mean patency than native AVFs. The most com-
mon causes of failure include the surgical twisting or
kinking of the graft during implantation, arterial plugs,
stenosis of the venous anastomosis or an unsuspected
venous stenosis. Venous stenosis results in problems
that have the net effect of causing inadequate dialysis.
Stenosis most frequently involves the venous anastomo-
sis, but it may occur anywhere within the system com-
posed by the graft, anastomosis and its draining veins.
Complete thrombosis is easily identified when it in-
volves the graft or the entire venous limb. Moreover,
AV grafts may produce complications related to arterial
inflow stenosis, arterial anastomotic stenosis, intragraft
stenosis, graft pseudoaneurysm and graft degeneration.
Treatment options are either a surgical revision or
endovascular stent graft placement.
Dialysis access catheters
The high thrombosis rate of AVF and PBGs and the high
recurrence rates after thrombolysis and angioplasty have led
to consideration of performing haemodialysis with percutane-
ously inserted venous catheters. Nowadays, venous catheters
are often taken into consideration as a long-term solution for
haemodialysis because of the improvement in biomaterials
available for catheters. Percutaneous venous catheters present
the advantage of being placed on an outpatient basis; more-
over, they do not require any maturation period, and they
prevent repeated punctures of the AVF. The disavantages are
represented by the fact that venous catheters are cosmetically
less acceptable, and the achievable peak of flow rates are
lower than with AVFs and PBGs.
A venous catheter positioned in a central vein (usually the
right internal jugular vein or, less frequently, the femoral or
subclavian veins) through the subclavian vein for a temporary
access has two chambers to allow a two-way flow of blood.
Once a catheter has been placed, the needle insertion is not
necessary. Catheters are not ideal for permanent access, and
their patency is maintained via a heparin-saline infusion by
flushing the catheter with 2 or 3 ml of heparin (2,000–3,000
units) twice daily (every 12 h). They can clog, become infect-
ed, and cause stenosis or complete thrombosis of the central
vein in which they are placed. However, if there is a need to
starting haemodialysis immediately, a catheter will work for
several weeks or months while the permanent access is grad-
ually developing.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
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